Skip to main content

Table 3 Most common treatment recommendations by LDL-C scenario

From: Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey

Recommendation

Scenario (% patients)

LDL-C observed BL RCT level (mg/dL)

1

2

3

LDL-C presumed near goal

LDL-C presumed far from goal

LDL-C level known at

100–105 mg/dL

 ~ 120 mg/dL

pre-randomization

No change in therapy

42.3

6.5

17.5

111.4

Double ATV dose

42.8

52.2

46.5

119.2

Add EZE

8.7

15.6

15.0

123.7

Double ATV dose and add EZE

2.0

11.6

9.3

129.3

Switch to RSV

1.0

4.3

2.6

124.8

  1. Values shown are mean values.
  2. ATV, atorvastatin; BL, baseline; EZE, ezetimibe; LDL-C, low-density lipoprotein cholesterol; RCT, randomized clinical trial; RSV, rosuvastatin.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X